Alkermes Plc  

(Public, NASDAQ:ALKS)   Watch this stock  
Find more results for Gordon Peterson�
-0.29 (-0.62%)
Apr 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 45.85 - 47.45
52 week 26.47 - 54.25
Open 47.23
Vol / Avg. 738,736.00/1.69M
Mkt cap 6.74B
P/E 375.54
Div/yield     -
EPS 0.12
Shares 144.19M
Beta 0.53
Inst. own 91%
May 28, 2014
Alkermes plc Annual Shareholder Meeting - 7:00AM EDT - Add to calendar
Apr 8, 2014
Alkermes Conference Call to discuss Positive Topline Results From Pivotal Phase 3 Study of Aripiprazole Lauroxil - Webcast
Mar 4, 2014
Alkermes plc at Credit Suisse Healthcare Conference
Mar 3, 2014
Alkermes plc at Cowen Health Care Conference
Feb 27, 2014
Q4 2013 Alkermes plc Earnings Release - Transition Period
Feb 27, 2014
Q4 2013 Alkermes plc Earnings Conference Call - Transition Period - Webcast
Feb 12, 2014
Alkermes plc at Leerink Swann Global Healthcare Conference - Webcast
Feb 10, 2014
Alkermes plc at Biotechnology Industry Organization CEO & Investor Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 11.70% 4.34%
Operating margin 3.78% 14.21%
EBITD margin - 29.75%
Return on average assets 4.69% 1.72%
Return on average equity 6.96% 2.77%
Employees 1,250 -
CDP Score - -


Connaught House 1 Burlington Road, Dublin 4
+353-1-7728000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. The Company manufactures RISPERDAL CONSTA, VIVITROL and polymer for BYDUREON in its Wilmington, Ohio facility. The Company operates PERDAL CONSTA lines and one VIVITROL line at commercial scale. The Company manufactures AMPYRA/FAMPYRA, RAPAMUNE and other products in its Athlone, Ireland facility. It manufactures FOCALIN XR, RITALIN LA, AVINZA, VERAPAMIL and other products in its Gainesville, Georgia facility.

Officers and directors

Richard F. Pops Chairman, President, and CEO
James M. (Jim) Frates SVP, CFO, and Treasurer
Gordon G. Pugh SVP, COO, and Chief Risk Officer
Richard F. Pops Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Shane Cooke President
Age: 51
Bio & Compensation  - Reuters
James M. Frates Chief Financial Officer, Senior Vice President
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gordon G. Pugh Chief Operating Officer, Senior Vice President, Chief Risk Officer
Age: 55
Bio & Compensation  - Reuters
Kathryn L. Biberstein Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James L. Botkin Senior Vice President - Operations
Age: 64
Bio & Compensation  - Reuters
Elliot W. Ehrich M.D. Senior Vice President - Research and Development, Chief Medical Officer
Age: 54
Bio & Compensation  - Reuters